Remove Diabetes Remove Download Remove Immunity
article thumbnail

How Your Pharmacy Can Participate in American Diabetes Month

Digital Pharmacist

November is American Diabetes Month – a time to come together to spread awareness about diabetes prevention and management. In this blog post, we’ll explore key ways pharmacies can actively participate in American Diabetes Month.

Diabetes 105
article thumbnail

Market Your Pharmacy with a 2023 Health Awareness Calendar

Digital Pharmacist

From cancer prevention to diabetes awareness, these events help bring communities together. World Immunization Week: April 24-30. National Immunization Awareness Month. National Diabetes Month. Cervical Health Awareness Month | S hare downloadable content from the NCCC and advocate for HPV vaccinations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novo Nordisk and Aspect join forces for bioprinting tissue therapeutics

Pharmaceutical Technology

The Canadian biotech Aspect Biosystems has announced a partnership with Novo Nordisk to produce bioprinted tissue therapeutics for diabetes. On April 12, the Dutch pharmaceutical giant Novo Nordisk announced a partnership to grow its diabetes portfolio. The company is developing therapeutic platforms for the liver and the pancreas.

article thumbnail

Why Balancing Blood Sugar is Vital for Hashimoto’s Health

The Thyroid Pharmacist

A review paper published in 2010 that discussed the relationship between thyroid dysfunction and metabolic disorders, highlighted the fact that patients with diabetes were up to three times more likely to develop a thyroid disorder. (7). Hypoglycemia is an early risk factor for developing diabetes. Type 2 Diabetes.

article thumbnail

M&A trends to watch out in pharma

Express Pharma

With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.

article thumbnail

M&A trends to watch out in pharma

Express Pharma

With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.

article thumbnail

Quell Therapeutics and AstraZeneca partner on Treg cell therapies

Pharmaceutical Technology

The partnership will use Quell’s toolbox of Treg cell engineering modules, which includes the Foxp3 phenotype lock, to create autologous multi-modular Treg cell therapy candidates to treat Type 1 diabetes (T1D) and inflammatory bowel disease (IBD).